[Treatment of stabilized auricular fibrillation with venous infusion of ajmaline in high doses combined with potassium aspartate].
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal; D011188:Potassium / Q000627:therapeutic use*; D011926:Rauwolfia / Q000008:administration & dosage*
D000889:Anti-Arrhythmia Agents; D001224:Aspartic Acid; D011188:Potassium
Il trattamento della fibrillazione atriale stabilizzata con infusioni venose di alte dosi di ajmalina associata ad aspartato di potassio.